Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 12 studies | 36% ± 16% | |
| endothelial cell | 8 studies | 24% ± 8% | |
| epithelial cell | 5 studies | 33% ± 14% | |
| fibroblast | 5 studies | 21% ± 5% | |
| GABAergic neuron | 5 studies | 31% ± 12% | |
| astrocyte | 5 studies | 22% ± 4% | |
| glutamatergic neuron | 4 studies | 40% ± 14% | |
| oligodendrocyte precursor cell | 4 studies | 29% ± 8% | |
| interneuron | 4 studies | 28% ± 16% | |
| microglial cell | 3 studies | 19% ± 1% | |
| lymphocyte | 3 studies | 17% ± 1% | |
| muscle cell | 3 studies | 22% ± 8% | |
| adipocyte | 3 studies | 20% ± 3% | |
| neuron | 3 studies | 35% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3327.20 | 1445 / 1445 | 100% | 83.78 | 183 / 183 |
| breast | 100% | 4104.27 | 459 / 459 | 100% | 122.25 | 1117 / 1118 |
| lung | 100% | 3320.99 | 578 / 578 | 100% | 90.76 | 1152 / 1155 |
| prostate | 100% | 4176.74 | 245 / 245 | 100% | 87.76 | 500 / 502 |
| uterus | 100% | 4630.50 | 170 / 170 | 100% | 93.80 | 457 / 459 |
| bladder | 100% | 4082.62 | 21 / 21 | 99% | 82.60 | 501 / 504 |
| brain | 100% | 3212.51 | 2639 / 2642 | 99% | 67.63 | 700 / 705 |
| thymus | 100% | 4063.73 | 653 / 653 | 99% | 65.34 | 600 / 605 |
| ovary | 100% | 5011.18 | 180 / 180 | 99% | 83.10 | 426 / 430 |
| pancreas | 100% | 2063.04 | 328 / 328 | 98% | 64.98 | 175 / 178 |
| stomach | 100% | 2676.17 | 359 / 359 | 98% | 71.25 | 280 / 286 |
| intestine | 100% | 3664.57 | 966 / 966 | 97% | 71.53 | 513 / 527 |
| skin | 100% | 4357.96 | 1809 / 1809 | 96% | 75.09 | 453 / 472 |
| kidney | 100% | 3092.38 | 89 / 89 | 96% | 47.39 | 864 / 901 |
| adrenal gland | 100% | 2866.83 | 258 / 258 | 94% | 40.84 | 216 / 230 |
| liver | 100% | 2311.89 | 226 / 226 | 92% | 36.13 | 373 / 406 |
| blood vessel | 100% | 3510.68 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 51.32 | 29 / 29 |
| muscle | 100% | 4317.52 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3259.22 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 75.48 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 40.47 | 1 / 1 |
| adipose | 100% | 3986.89 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| heart | 99% | 2506.19 | 849 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 85% | 37.84 | 68 / 80 |
| peripheral blood | 47% | 1906.91 | 440 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006355 | Biological process | regulation of DNA-templated transcription |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005829 | Cellular component | cytosol |
| GO_0005634 | Cellular component | nucleus |
| GO_0003677 | Molecular function | DNA binding |
| GO_0008201 | Molecular function | heparin binding |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0008270 | Molecular function | zinc ion binding |
| Gene name | ZNF146 |
| Protein name | Zinc finger protein OZF (Only zinc finger protein) (Zinc finger protein 146) |
| Synonyms | OZF |
| Description | |
| Accessions | Q15072 ENST00000456324.5 ENST00000443387.3 |